Nureca Limited
Nureca Limited provides home healthcare and wellness products in India. The company offers chronic disease products, such as nebulizers, blood pressure monitors, finger pulse oximeters, glucose meters, and thermometers, as well as connected products; orthopedic products, including massagers, pain management products, posture correctors, and rehabilitation products; and humidifiers and steamers, p… Read more
Market Cap & Net Worth: Nureca Limited (NURECA)
Nureca Limited (NSE:NURECA) has a market capitalization of $27.37 Million (₹2.37 Billion) as of March 19, 2026. Listed on the NSE stock exchange, this India-based company holds position #29558 globally and #1624 in its home market, demonstrating a -8.53% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Nureca Limited's stock price ₹248.40 by its total outstanding shares 9541920 (9.54 Million).
Nureca Limited Market Cap History: 2021 to 2026
Nureca Limited's market capitalization history from 2021 to 2026. Data shows change from $220.44 Million to $27.37 Million (-17.15% CAGR).
Nureca Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Nureca Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.03x
Nureca Limited's market cap is 0.03 times its annual revenue
0.67x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
4.01x
Nureca Limited's market cap is 4.01 times its annual earnings
1.94x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $220.44 Million | $2.13 Billion | $463.74 Million | 0.10x | 0.48x |
| 2022 | $54.89 Million | $2.56 Billion | $449.60 Million | 0.02x | 0.12x |
| 2023 | $47.15 Million | $1.11 Billion | -$82.50 Million | 0.04x | N/A |
| 2024 | $31.18 Million | $919.28 Million | -$17.94 Million | 0.03x | N/A |
| 2025 | $33.93 Million | $1.10 Billion | $8.46 Million | 0.03x | 4.01x |
Competitor Companies of NURECA by Market Capitalization
Companies near Nureca Limited in the global market cap rankings as of March 19, 2026.
Key companies related to Nureca Limited by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #84 globally with a market cap of $187.53 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #151 globally with a market cap of $119.88 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #170 globally with a market cap of $111.60 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #183 globally with a market cap of $105.38 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #84 | Abbott Laboratories | NYSE:ABT | $187.53 Billion | $108.49 |
| #151 | Stryker Corporation | NYSE:SYK | $119.88 Billion | $345.81 |
| #170 | Medtronic PLC | NYSE:MDT | $111.60 Billion | $87.21 |
| #183 | Boston Scientific Corp | NYSE:BSX | $105.38 Billion | $71.28 |
Nureca Limited Historical Marketcap From 2021 to 2026
Between 2021 and today, Nureca Limited's market cap moved from $220.44 Million to $ 27.37 Million, with a yearly change of -17.15%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₹27.37 Million | -19.34% |
| 2025 | ₹33.93 Million | +8.84% |
| 2024 | ₹31.18 Million | -33.87% |
| 2023 | ₹47.15 Million | -14.10% |
| 2022 | ₹54.89 Million | -75.10% |
| 2021 | ₹220.44 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of Nureca Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $27.37 Million USD |
| MoneyControl | $27.37 Million USD |
| MarketWatch | $27.37 Million USD |
| marketcap.company | $27.37 Million USD |
| Reuters | $27.37 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.